Log In
Print this Print this

PCSK9 vaccine

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionVaccine targeting proprotein convertase subtilisin/kexin type 9 (PCSK9)
Molecular Target Proprotein convertase subtilisin/kexin type 9 (PCSK9)
Mechanism of Action 
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationHypercholesterolemia
Indication DetailsLower low-density lipoprotein (LDL)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today